Due to an increasing incidence of type 1 diabetes in France, Germany, Italy, Spain, and the UK and a steady incidence in the United States, which still has a growing population of children and adolescents, there will be an increase in the number of cases of type 1 diabetes in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK over the next ten years.
Features and benefits
- Gain insight to market potential, including a robust 10-year epidemiology forecast of type 1 diabetes incident cases.
- Understand the current burden of disease with Datamonitor's 2010 type 1 diabetes prevalence estimate.
Type 1 diabetes is a metabolic disorder which can cause serious illness and death if not managed properly with insulin administration. The only risk factor shown to be significantly associated with the risk of type 1 diabetes is genetics and several genes have been linked to the risk.Datamonitor estimates that there will be a marginal increase or steady incidence of cases of type 1 diabetes in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) between 2010 and 2020.Datamonitor estimates that there are approximately 2.7 million prevalent cases of type 1 diabetes mellitus in those aged under 80 in the year 2010.
Your key questions answered
- Which are the most robust epidemiologic studies for type 1 diabetes incidence and prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure or risk factors affect the trend in incident type 1 diabetes cases?